How are "ziconotide-first" protocols and 2026's opioid-stewardship programs changing the drug delivery mix?
In 2026, the "opioid-sparing" movement has reached the world of spinal delivery, with the intrathecal pumps market seeing a surge in non-opioid medications like ziconotide. Traditionally, morphine was the primary choice, but in 2026, updated PACC (Polyanalgesic Consensus Conference) guidelines are increasingly recommending ziconotide—a non-opioid derived from marine snail venom—as a...
0 Comments 0 Shares 20 Views 0 Reviews